The use of systemic and topical fluoroquinolones

Committee on Infectious Diseases

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Appropriate prescribing practices for fluoroquinolones, as well as all antimicrobial agents, are essential as evolving resistance patterns are considered, additional treatment indications are identified, and the toxicity profile of fluoroquinolones in children has become better defined. Earlier recommendations for systemic therapy remain; expanded uses of fluoroquinolones for the treatment of certain infections are outlined in this report. Prescribing clinicians should be aware of specific adverse reactions associated with fluoroquinolones, and their use in children should continue to be limited to the treatment of infections for which no safe and effective alternative exists or in situations in which oral fluoroquinolone treatment represents a reasonable alternative to parenteral antimicrobial therapy.

Original languageEnglish (US)
Article numbere20162706
JournalPediatrics
Volume138
Issue number5
DOIs
StatePublished - Nov 2016

Fingerprint

Fluoroquinolones
Therapeutics
Anti-Infective Agents
Infection

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Committee on Infectious Diseases (2016). The use of systemic and topical fluoroquinolones. Pediatrics, 138(5), [e20162706]. https://doi.org/10.1542/peds.2016-2706

The use of systemic and topical fluoroquinolones. / Committee on Infectious Diseases.

In: Pediatrics, Vol. 138, No. 5, e20162706, 11.2016.

Research output: Contribution to journalArticle

Committee on Infectious Diseases 2016, 'The use of systemic and topical fluoroquinolones', Pediatrics, vol. 138, no. 5, e20162706. https://doi.org/10.1542/peds.2016-2706
Committee on Infectious Diseases. The use of systemic and topical fluoroquinolones. Pediatrics. 2016 Nov;138(5). e20162706. https://doi.org/10.1542/peds.2016-2706
Committee on Infectious Diseases. / The use of systemic and topical fluoroquinolones. In: Pediatrics. 2016 ; Vol. 138, No. 5.
@article{2af32a2c58c94dfbbd19c0a7ef4a1aeb,
title = "The use of systemic and topical fluoroquinolones",
abstract = "Appropriate prescribing practices for fluoroquinolones, as well as all antimicrobial agents, are essential as evolving resistance patterns are considered, additional treatment indications are identified, and the toxicity profile of fluoroquinolones in children has become better defined. Earlier recommendations for systemic therapy remain; expanded uses of fluoroquinolones for the treatment of certain infections are outlined in this report. Prescribing clinicians should be aware of specific adverse reactions associated with fluoroquinolones, and their use in children should continue to be limited to the treatment of infections for which no safe and effective alternative exists or in situations in which oral fluoroquinolone treatment represents a reasonable alternative to parenteral antimicrobial therapy.",
author = "{Committee on Infectious Diseases} and Jackson, {Mary Anne} and Schutze, {Gordon E.} and Byington, {Carrie L.} and Maldonado, {Yvonne A.} and Barnett, {Elizabeth D.} and Campbell, {James D.} and Davies, {Herbert Dele} and Ruth Lynfield and Munoz, {Flor M.} and Dawn Nolt and Nyquist, {Ann Christine} and Sean O'Leary and Rathore, {Mobeen H.} and Sawyer, {Mark H.} and Steinbach, {William J.} and Tan, {Tina Q.} and Zaoutis, {Theoklis E.}",
year = "2016",
month = "11",
doi = "10.1542/peds.2016-2706",
language = "English (US)",
volume = "138",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "5",

}

TY - JOUR

T1 - The use of systemic and topical fluoroquinolones

AU - Committee on Infectious Diseases

AU - Jackson, Mary Anne

AU - Schutze, Gordon E.

AU - Byington, Carrie L.

AU - Maldonado, Yvonne A.

AU - Barnett, Elizabeth D.

AU - Campbell, James D.

AU - Davies, Herbert Dele

AU - Lynfield, Ruth

AU - Munoz, Flor M.

AU - Nolt, Dawn

AU - Nyquist, Ann Christine

AU - O'Leary, Sean

AU - Rathore, Mobeen H.

AU - Sawyer, Mark H.

AU - Steinbach, William J.

AU - Tan, Tina Q.

AU - Zaoutis, Theoklis E.

PY - 2016/11

Y1 - 2016/11

N2 - Appropriate prescribing practices for fluoroquinolones, as well as all antimicrobial agents, are essential as evolving resistance patterns are considered, additional treatment indications are identified, and the toxicity profile of fluoroquinolones in children has become better defined. Earlier recommendations for systemic therapy remain; expanded uses of fluoroquinolones for the treatment of certain infections are outlined in this report. Prescribing clinicians should be aware of specific adverse reactions associated with fluoroquinolones, and their use in children should continue to be limited to the treatment of infections for which no safe and effective alternative exists or in situations in which oral fluoroquinolone treatment represents a reasonable alternative to parenteral antimicrobial therapy.

AB - Appropriate prescribing practices for fluoroquinolones, as well as all antimicrobial agents, are essential as evolving resistance patterns are considered, additional treatment indications are identified, and the toxicity profile of fluoroquinolones in children has become better defined. Earlier recommendations for systemic therapy remain; expanded uses of fluoroquinolones for the treatment of certain infections are outlined in this report. Prescribing clinicians should be aware of specific adverse reactions associated with fluoroquinolones, and their use in children should continue to be limited to the treatment of infections for which no safe and effective alternative exists or in situations in which oral fluoroquinolone treatment represents a reasonable alternative to parenteral antimicrobial therapy.

UR - http://www.scopus.com/inward/record.url?scp=84994885383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994885383&partnerID=8YFLogxK

U2 - 10.1542/peds.2016-2706

DO - 10.1542/peds.2016-2706

M3 - Article

C2 - 27940800

AN - SCOPUS:84994885383

VL - 138

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 5

M1 - e20162706

ER -